These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1803782)

  • 1. [The cultivation of the vaccinal rabies virus in continuous green monkey cell lines].
    Aksenova TA; Khapchaev IuKh; Mironova LL; Soshenko IuV; Selimov MA; Khozinskiĭ VV
    Vopr Virusol; 1991; 36(5):432-3. PubMed ID: 1803782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cultivation of the rabies virus in the continuous kidney cell line 4647 from the green marmoset].
    Aksenova TA; Mironova LL; Grachev VP; Selimov MA; Preobrazhenskaia NK
    Vopr Virusol; 1985; 30(2):180-2. PubMed ID: 2408382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economical production of rabies vaccine on cell cultures].
    Lalosević D; Lazarević-Ivanc L; Stankov S
    Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new antirabies vaccine for human use prepared on cultured cells].
    Petrović M; Damjanović J
    Med Pregl; 1979; 32(7-8):313-7. PubMed ID: 522829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
    Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies virus production in high vero cell density cultures on macroporous microcarriers.
    Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA
    Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell].
    Shi XS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask.
    Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A
    Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adaptation of a fixed rabies virus to monkey kidney cells. Use of this virus for the preparation of an inactivated anti-rabies vaccine].
    Lang R; Petermann HG; Branche R; Soulebot JP
    C R Acad Hebd Seances Acad Sci D; 1969 Dec; 269(22):2287-90. PubMed ID: 4983278
    [No Abstract]   [Full Text] [Related]  

  • 14. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the herpetic virus on human diploid and monkey kidney cells.
    Mihăilescu R; Petraşincu DE; Brestoiu S
    Roum Arch Microbiol Immunol; 1992; 51(3):137-40. PubMed ID: 1338423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of the incubation period of the fixed Babeş strain in relation to the nature of the host cells. The effects on viral titer and on the immunogenic value of rabies vaccines].
    Serban O; Toacsen E
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):87-91. PubMed ID: 6336510
    [No Abstract]   [Full Text] [Related]  

  • 17. Modified live-virus rabies vaccine produced from flury high egg-passage virus grown on an established canine-kidney cell line: three-year duration-of-immunity study in dogs.
    Brown AL; Merry DL; Beckenhauer WH
    Am J Vet Res; 1973 Nov; 34(11):1427-32. PubMed ID: 4748726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the interfering activity of the Vnukovo-32 vaccinal strain of the rabies virus].
    Romanova LN
    Vopr Virusol; 1973; 18(2):227-30. PubMed ID: 4350240
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of neuroblastoma cells to rabies virus may be affected by passage number.
    Pouliott C; Dupuis M; Appler K; Brunt S; Rudd R; Davis A
    J Virol Methods; 2017 Sep; 247():28-31. PubMed ID: 28506631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabies vaccines for veterinary use.
    Croghan DL
    J Am Vet Med Assoc; 1970 Jun; 156(12):1798-801. PubMed ID: 5422529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.